Shanghai Fosun Pharmaceutical (Group) Co Cash Flow
SFOSF's free cash flow for Q3 2024 was ¥―. For the 2024 fiscal year, SFOSF's free cash flow was decreased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
Cash Flow
Dec 23
Dec 22
Dec 21
Dec 20
Dec 19
Operating Cash Flow
¥ 3.41B
¥ 4.22B
¥ 3.95B
¥ 2.58B
¥ 3.22B
Investing Cash Flow
¥ -3.82B
-
-
-
-
Financing Cash Flow
-
¥ 4.43B
-
¥ 1.47B
-
End Cash Position
¥ 9.50B
¥ 11.17B
¥ 6.45B
¥ 7.32B
¥ 8.28B
Free Cash Flow
-
-
-
-
-
Currency in CNY
Shanghai Fosun Pharmaceutical (Group) Co Cash Flow